Geoffrey Allan has been giving Congress a lesson in biotechnology.Let's hope Congress approves Allan's idea, because these drugs could help cancer patients.
He's explained protein structures and how they work. He's reviewed how drugs are absorbed into the body.
If lawmakers understand the difference between chemical and biologic drugs, Allan reasons, they'll be more invested in his cause: getting quick approval for generic biotech drugs.
Today the generics market for chemical drugs like aspirin is booming, but there is no way to get cheaper copies of pricey biologics, for complex life-threatening diseases like cancer, into patients' hands.